Amato L, Omodei D, De Rosa C, Ariano A, Capaldo S, Tufano C
Cancers (Basel). 2024; 16(23).
PMID: 39682133
PMC: 11639923.
DOI: 10.3390/cancers16233941.
Zhang Y, Pan R, Li K, Cheang L, Zhao J, Zhong Z
Int J Biol Sci. 2024; 20(13):5162-5190.
PMID: 39430254
PMC: 11489178.
DOI: 10.7150/ijbs.100015.
Li G, Miao Y, Chen H, Xue M, Wang J, Zhang J
Am J Cancer Res. 2024; 14(5):2072-2087.
PMID: 38859866
PMC: 11162665.
DOI: 10.62347/XFJH3424.
Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola F
Nat Rev Drug Discov. 2024; 23(6):445-460.
PMID: 38622310
PMC: 11153000.
DOI: 10.1038/s41573-024-00920-9.
Wei L, Deng C, Zhang B, Wang G, Meng Y, Qin H
Mol Cancer Res. 2023; 22(1):55-69.
PMID: 37768180
PMC: 10758695.
DOI: 10.1158/1541-7786.MCR-22-0835.
RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy.
Chang H
Biomedicines. 2023; 11(9).
PMID: 37760968
PMC: 10526535.
DOI: 10.3390/biomedicines11092527.
Stress granules and hormetic adaptation of cancer.
Redding A, Grabocka E
Trends Cancer. 2023; 9(12):995-1005.
PMID: 37704502
PMC: 10843007.
DOI: 10.1016/j.trecan.2023.08.005.
Mapping the landscape of genetic dependencies in chordoma.
Sharifnia T, Wawer M, Goodale A, Lee Y, Kazachkova M, Dempster J
Nat Commun. 2023; 14(1):1933.
PMID: 37024492
PMC: 10079670.
DOI: 10.1038/s41467-023-37593-8.
Targeting protein folding in N-Myc-driven medulloblastoma.
Valinciute G, Roussel M
Mol Oncol. 2023; 17(3):387-389.
PMID: 36786675
PMC: 9980298.
DOI: 10.1002/1878-0261.13395.
and mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma.
Morgan K, Doggett K, Geng F, Mieruszynski S, Whitehead L, Smith K
Elife. 2023; 12.
PMID: 36648336
PMC: 9897728.
DOI: 10.7554/eLife.73407.
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
Papaccio F, Garcia-Mico B, Gimeno-Valiente F, Cabeza-Segura M, Gambardella V, Gutierrez-Bravo M
J Exp Clin Cancer Res. 2023; 42(1):8.
PMID: 36604765
PMC: 9817273.
DOI: 10.1186/s13046-022-02591-z.
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies.
Orlando E, Medo M, Bensimon A, Quintin A, Riedo R, Roth S
Cell Mol Life Sci. 2022; 80(1):6.
PMID: 36494469
PMC: 9734221.
DOI: 10.1007/s00018-022-04634-2.
HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma.
Cheng H, Wang S, Huang A, Ma J, Gao D, Li M
Cancer Biol Ther. 2022; 24(1):1-9.
PMID: 36482717
PMC: 9746510.
DOI: 10.1080/15384047.2022.2156242.
Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers.
Singh N, Romick-Rosendale L, Watanabe-Chailland M, Privette Vinnedge L, Komurov K
PLoS One. 2022; 17(12):e0256788.
PMID: 36480552
PMC: 9731458.
DOI: 10.1371/journal.pone.0256788.
Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic Cancer.
Fazzari F, Chow S, Cheung M, Barghout S, Schimmer A, Chang Q
ACS Pharmacol Transl Sci. 2022; 5(11):1070-1078.
PMID: 36407947
PMC: 9667549.
DOI: 10.1021/acsptsci.2c00170.
NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations.
Le Y, Gao H, Zhu A, Felt K, Rodig S, Bleday R
iScience. 2022; 25(11):105426.
PMID: 36388981
PMC: 9641229.
DOI: 10.1016/j.isci.2022.105426.
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Kuzuoglu-Ozturk D, Aksoy O, Schmidt C, Lea R, Larson J, Phelps R
Cancer Res. 2022; 83(1):130-140.
PMID: 36264168
PMC: 9812901.
DOI: 10.1158/0008-5472.CAN-22-0945.
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia.
Dong Q, Xiu Y, Wang Y, Hodgson C, Borcherding N, Jordan C
Nat Commun. 2022; 13(1):6107.
PMID: 36245043
PMC: 9573868.
DOI: 10.1038/s41467-022-33861-1.
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?.
Kuo C, Babuharisankar A, Lin Y, Lien H, Lo Y, Chou H
J Biomed Sci. 2022; 29(1):74.
PMID: 36154922
PMC: 9511749.
DOI: 10.1186/s12929-022-00859-2.
The mitochondrial unfolded protein response (UPR): shielding against toxicity to mitochondria in cancer.
Inigo J, Chandra D
J Hematol Oncol. 2022; 15(1):98.
PMID: 35864539
PMC: 9306209.
DOI: 10.1186/s13045-022-01317-0.